abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

24 Nov 2010

Author:
Phil Milford and Jef Feeley, Bloomberg

Pfizer Loses Appeal of $58 Million Prempro Jury Award [USA]

Pfizer…must pay a $57.6 million jury award to three women who alleged the pills caused their cancers, the state’s highest court ruled. The Nevada Supreme Court concluded...Pfizer’s Wyeth unit responsible for hiding the breast-cancer risks of its Premarin and Prempro menopause drugs…Pfizer spokesman Christopher Loder said the company is disappointed with the decision and is considering further appeal…[The plaintiffs] alleged Wyeth officials ignored Prempro’s health risks and failed to properly warn doctors and consumers about the drug’s cancer link to boost profits…